
æ¥æ¬ã®ç ç©¶ã§ãmRNA泚å°ã¯èµèããæ£è ã®äºåŸäžè¯ãšé¢é£ããããšã瀺ããã
å èšäºã¯ãã¡ããã/Click here to read the original article.
æ¥æ¬ã®ç ç©¶ã§ã¯ãç¹°ãè¿ãã®COVID mRNAã¯ã¯ãã³æ¥çš®ãèµèçæ£è
ã®å
šäœçãªçåçã®äœäžãšé¢é£ããŠããããšãæããã«ãªããŸããããã®ãã¬ããªã³ãç ç©¶ã¯4æ15æ¥ã«çºè¡šãããŸããã
ãã®ç¿æ¥ãäžçä¿å¥æ©é¢ïŒWHOïŒã¯ãmRNAã¯ã¯ãã³ã®å
±æãä¿é²ããããšãå«ãåœéçãªãã³ãããã¯åå®ã®èæ¡ãæçµåããŸããããã®èæ¡ã¯ãæ¥æã®äžçä¿å¥ç·äŒã§WHOå çåœã®ã代衚è
ãã«ãã£ãŠæ¡æãããäºå®ã§ãã
æ·±å»ãªå¯äœçšãmRNAã¯ã¯ãã³æ¥çš®åŸã®æ»äº¡çã®å¢å ã«é¢ãã蚌æ ããŸããŸãå¢ããŠããäžã§ãWHOã¯ãã®è°é¡ãé²ããŠããããšã¯ãé©ãã¹ãåãã§ããã¹ãã§ããããã¯ãé©ãã¹ãããšã§ã¯ãªããªã£ãŠããŸãã
ç»æçãªç ç©¶ãç¹°ãè¿ãã®mRNAã¯ã¯ãã³æ¥çš®ãçã®é²è¡ã«å¯Ÿããè匱æ§ãé«ããããšãçºèŠ
èè : ã¬ã€ã»ãããã£ãŒãå士ã2025幎4æ19æ¥
ãã®èšäºã§ã¯ãçåœãæ¯é ããèªç¶ã®æ³åã®ååã«æ·±ãèžã¿èŸŒã¿ãæè¿çºè¡šãããç§åŠè«æã«åºã¥ãæ ¹æ¬çãªåé¡ãæç€ºãããã®è§£æ±ºçãææ¡ããŸãã
幞ããªããšã«ãäžçäžã®è²¬ä»»ããç§åŠè ãã¡ã¯ãäžççãªmRNA COVID-19ã¯ã¯ãã³æ¥çš®ããã°ã©ã ãããããã圱é¿ãåŒãç¶ã調æ»ããŠããŸãããã®ããã°ã©ã ã¯åèšã§130åååã®æ¥çš®ã宿œããŸããã
æ¥æ¬ã®ç§åŠè ãã¡ã¯ãCOVID-19ã¯ã¯ãã³ãèµèçïŒPCïŒæ£è ã«äžãã圱é¿ã«é¢ããç ç©¶ã宿ããããRepeated Covid-19 Vaccination as a Poor Prognostic Factor in Pancreatic Cancer: A Retrospective, Single-Centre Cohort Studyããšããã¿ã€ãã«ã®ç ç©¶ãçºè¡šããŸããããã®ç ç©¶ã¯äžççãªåœ±é¿ãäžããŠãããçºè¡šãã1æ¥ã§4,000å以äžããŠã³ããŒããããŠããŸãã
ç ç©¶ã¯ãmRNAæè¡ããéèŠãªæè¡ç鲿©ããšããŠç€Œè³ãããã®è©äŸ¡ãå°ãæ§ããã«ããªããå§ãŸããŸãããããã¯è«æãåºçãããããã«å¿ èŠãªè¡šçŸïŒã¯ãããžã£ãŒãã«ã¯ãŸã ãã®å¹»æ³ã«ããã¿ã€ããŠããŸãïŒã§ãã
ãã®åŸãçã®è匱æ§ã«é¢ãã詳现ãªè©±ã«é²ã¿ãŸããç ç©¶ã¯ã2018幎1æãã2023幎11æãŸã§ã«åç é¢ã«å ¥é¢ãã272人ã®èµèçæ£è ã®çåçã«å¯ŸããCOVID-19ã¯ã¯ãã³æ¥çš®ã®åœ±é¿ã調æ»ããŸããã
èµèçã¯é²è¡ãæ©ããçåçãäœãïŒ5幎åŸã§çŽ10-12%ïŒçã§ããå€ãã®å Žåãæ¢ã«åšå²ã®æ§é ã«æµžæœ€ããŠãããæçµçã«ã¯ä»ã®éšåã«è»¢ç§»ããŸãããã®æ¥æ¬ã®ç ç©¶ã§ã¯ãç¹°ãè¿ãã®COVID-19ããŒã¹ã¿ãŒæ¥çš®ãèµèçæ£è ã®å šäœçãªçåçã®äœäžãšé¢é£ããŠããããšãçºèŠãããŸããã
æ£è ã®è»¢åž°ã¯2020幎ãŸã§ã¯æ¹åããŠããŸãããã2021幎ããã¯æªåãã2022幎ãã2023幎ã®è»¢åž°ã¯2018幎ãã2021幎ã®è»¢åž°ãããå€§å¹ ã«æªåããŠããŸããã
ç ç©¶ã®èè ãã¡ã¯ãå¯èœãªã¡ã«ããºã ã調æ»ãã以äžã®ããã«çµè«ããŸããïŒåŒ·èª¿è¿œå ïŒïŒ
ãæ³šç®ãã¹ãã¯ãã¯ã¯ãã³æ¥çš®ã«ãã£ãŠèªçºãããIgG4ïŒå ç«æå¶å åïŒãããããã®æ£è ã®äºåŸã«æªåœ±é¿ãäžããããšãçžé¢ããŠãããšããåæçµæã§ãããããã®ç¥èŠã¯ãã¯ã¯ãã³æ¥çš®ãšçé²è¡ãšã®çžäºäœçšã«ã€ããŠéèŠãªæ å ±ãæäŸããæ£è ç®¡çæŠç¥ã«å€§ããªåœ±é¿ãäžããå¯èœæ§ããããŸããç§ãã¡ã®ç ç©¶ã¯ãmRNAã¯ã¯ãã³ãçã®äºåŸã«äžããé·æçãªåœ±é¿ã«é¢ããç¶ç¶çãªç ç©¶ã®å¿ èŠæ§ã匷調ããŠãããããã¯å ¬è¡è¡çãçæ²»çã®é²å±ã«ãããŠéèŠãªèª²é¡ã§ããã
çµ±èšåæã¯ãå¹Žéœ¢ãæ§å¥ã䜵åçŸæ£ãæ²»çæŽãã¯ã¯ãã³æ¥çš®æŽãªã©ãèæ ®ããã°ã«ãŒãã調æŽããŸãããå šäœçã«ãCOVID-19ã¯ã¯ãã³ã2åæ¥çš®ãã人ã¯ã3åæ¥çš®ãã人ãããé·ãçåããŸããïŒp=0.006ïŒã埮çç©åŠçãã¹ãã§ã¯ã3åæ¥çš®ããã°ã«ãŒãã¯2åæ¥çš®ããã°ã«ãŒãã«æ¯ã¹ãŠå ç«åå¿ãäœäžããŠããããšã確èªãããŸããããã®ç ç©¶ã¯ä»ã®çã¿ã€ãã®è»¢åž°ã調ã¹ãŠããŸããããã®çç¥ã«ã€ããŠã¯ãçããèªèº«ã§èæ ®ããŠããã ããã°ãšæããŸãã
æªè§£æ±ºã®è¬ã¯ããªãç§ãã¡ã®å¥åº·ã·ã¹ãã ãäŸç¶ãšããŠmRNA COVID-19ã¯ã¯ãã³æ¥çš®ãæšå¥šãç¶ããŠããã®ããšããããšã§ãããã®ç ç©¶ã®çºè¡šã¯ã以åã«å ±åããå€ãã®ç ç©¶ã®çºè¡šã«ç¶ããã®ã§ãæ·±å»ãªå¯äœçšãmRNAã¯ã¯ãã³æ¥çš®åŸã®æ»äº¡çã®å¢å ãææžåããŠããŸããããããåã4æ16æ¥ã«ãäžçä¿å¥æ©é¢ïŒWHOïŒã¯ãå°æ¥ã®ãã³ãããã¯ãžã®å¯Ÿå¿æ¹æ³ã«ã€ããŠãå çåœïŒãã¥ãŒãžãŒã©ã³ããå«ãïŒéã§æ³çææåã®ããåæãçºè¡šããŸããããã®åæã®äžå¿ã«ã¯ãå¯è£åœãšè²§å°åœã®éã§è¬ãã¯ã¯ãã³ããå ±æãããããšãå«ãŸããŠããŸããããããããå ±æãããããæ¡æ£ããšããèšèãé©åãããããŸããã
åœã®æ¬è³ªã¯æé·ããããš
ãªããäžçã®ããããå»åŠã®å°éå®¶ãã¡ããããã®é²è¡ãä¿é²ããã¯ã¯ãã³æ¥ç𮿹æ³ãä»ã§ãæšå¥šããŠããã®ã§ããããïŒãã®çãã¯ãçåœã®æ¬è³ªã«ã€ããŠã®æ ¹æ¬çãªèª€è§£ã«ãããŸãã1953幎ã«DNAãçºèŠãããããšã«ãã£ãŠãçåœã®éµãçºèŠããããã以äžçåœã®æœè±¡çãªåºç€ã«ã€ããŠèšãããšã¯ã»ãšãã©ãªããšããç¥è©±ã確ç«ãããŸããããã®ããšããå»åŠç ç©¶ã®çŠç¹ãDNAã®ç·šéãšãã®çµæã®æž¬å®ã«åããããããšã«ãªããŸããããããã¯æ¬è³ªçã«çåœã«å¯ŸããŠç Žå£çãªã¢ãããŒãã§ãã
DNAã®çºèŠã®æ·±ãæå³ã¯ããªãããã€ãªãã¯ãããžãŒã®åéã§ã¯èŠéãããŠããŸããDNAã¯çåœãèªããæ°žç¶ãããççåŠçãªã¡ã«ããºã ã§ããç°¡åã«èšããšãçåœã®æ¬è³ªã¯æé·ããããšã§ããDNAã®ç·šéã¯ãèªå·±æ°žç¶ã詊ã¿ãããšã«ãªããããã¯ã»ãŒçã®å®çŸ©ãšãèšããŸãã
å ç«ã·ã¹ãã ã¯ãåã ã®DNAã®ç¬èªã®ç¹åŸŽãå®ãããã«å°å¿µããŠããŸããããã¯ã24æéã®éã«äœå åãã®å¶çºçãªå€ç°ãä¿®æ£ããŠããŸãããã®ãããªç¶æ³ã®äžã§ãDNAãç ç©¶ããŠãã人ã ã¯ãç·šéããDNAãå ç«ã·ã¹ãã ã«ãã£ãŠæçµ¶ãããªãããã«ããæ¹æ³ããšãããåé¡ãã解決ããããšããŠããŸããèšãæããã°ãç·šéãããDNAãæé·ããæ©äŒãäžããæ¹æ³ãæ¢ããŠããã®ã§ãããã®ãããå ç«åå¿ãåé¿ãŸãã¯åæ¢ãããææ®µã詊ãããŠããŸãïŒè©³çްã«ã€ããŠã¯ããã§è°è«ãããŠããŸãïŒãåã³ãç§ãã¡ã¯çã®åé¡ã«è¡ãçããŸãã
ãJournal of Clinical Neuroscienceãã«çºè¡šãããç ç©¶ãExpression of SARS-CoV-2 spike protein in cerebral Arteries: Implications for haemorrhagic stroke post-mRNA vaccinationãã¯ãããã«åœŒããéºäŒåç·šéãæ°žç¶ãããããšã«æåãããã確èªããŠããŸãã
ãã®ç ç©¶ã¯ãmRNAã¯ã¯ãã³æ¥çš®åŸ17ãæä»¥å ã«å¥³æ§ã®è³åäžæ£è ã®ã»ãŒåæ°ã«è³åèã«COVID-19ã¹ãã€ã¯ã¿ã³ãã¯è³ªãååšããŠããããšãçºèŠããŸãããããã«ã¯ãçç现èã®æµžæœ€ã䌎ã£ãŠããŸããããã®çºèŠã¯ãã¹ãã€ã¯ã¿ã³ãã¯è³ªãäœå ã®ä»ã®éšäœã«é·æéååšããŠããããšã瀺ãä»ã®ç ç©¶çµæã匷åããŠããŸãããããæå³ãããšããã¯æçœã§ãïŒCOVID-19ã¯ã¯ãã³ã®éºäŒåé åã¯ãåããè ã®éºäŒçæ©èœã«é·æçã«å¹²æžããŠããå¯èœæ§ããããšããããšã§ããããã¯æãŸããã容èªãã¹ãçµæã§ããããŸããã
ç§ãã¡ã®çްèéºäŒåã·ã¹ãã ã¯é©ç°çã§ãããã¹ãŠã®çްèã«ã¯å šã²ãã ãå«ãŸããŠããããã®å šäœãããããéšåã«å«ãŸããŠããŸãããããããã®å šäœã¯éšåã®åèšä»¥äžã®ãã®ã§ãããã®åµé çç¥æ§ã®ç§åŠïŒSCIïŒã®ååã¯ãåäžã®çç©ã«ã ãé©çšãããã®ã§ã¯ãªãããã¹ãŠã®çš®ã®åºç€ã«çްèDNAããããšããæå³ã§ããã¹ãŠã®çš®ã«é©çšãããŸããäœçŸäžçš®é¡ãã®çç©ãå ±åããäžçã¯ã1ã€ã®ãå šäœçãªãããã¯ãŒã¯ãã圢æããŠããŸãã
ãã®åºå€§ãªãããã¯ãŒã¯ã§ã¯ã圱é¿ãæ å ±ãæ é€ãåžžã«çžäºã«äº€æãããŠããããã¹ãŠã现èéºäŒåŠã«å«ãŸããæ§é çãã€åçãªç¥æ§ã«åºã¥ããŠããŸããã·ã¹ãã å šäœã«ã¯ç§©åºãååšããããã¯ã©ã³ãã ã§ã¯ãããŸãããã·ã¹ãã å šäœã¯ç©çåŠã«ãã£ãŠèª¿æ»ãããèªç¶ã®æ³åã«åºã¥ããŠããŸãããéèŠãªã®ã¯ããããæèãšããæé«ã®ç¥æ§ã®è¡šçŸã§ããããšããããšã§ãããããã£ãŠãçåœã¯æèã®åºç€ã®äžã«å±€ãšããŠç¯ãããŠããã®ã§ããå€åŽã¯å åŽã«äŸåããŠããŸãã
ããã§çè§£ããªããã°ãªããªãéèŠãªããšã¯ãçŸåšé²è¡äžã®èªç¶æ³åã®ç§©åºã«å¯Ÿããå šé¢çãªæ»æã§ããç§ãã¡ãå ±åããããã«ãç§ãã¡ã®é£ææºïŒç©ç©ãéèïŒãé£åå å·¥ïŒéºäŒåçµã¿æã埮çç©ã䜿çšïŒãçç©ïŒåç©ãæè«ïŒãå»çä»å ¥ãåç²§åã®éºäŒåå·¥åŠã¯ãèªç¶çãç§ãã¡ã®ç掻ã«ãããããªã¹ãã£ãã¯ãªç§©åºãè ãããŠããŸãããããã®æ¹å€ãããèŠçŽ ã¯ãéºäŒåã·ã¹ãã ã®æ§è³ªã«åŸãããäºãã«çãæ®ããæé·ããæ¢åã®èªç¶ããã»ã¹ãä¹ã£åãããšããŠããŸãããããã¯ãäœçŸäžå¹Žã«ãããçžäºã«æçãªé²åã«åºã¥ãå šäœçãªãã®ã§ã¯ãªããäœçŸäžåã«ãåã¶äººçºçã§ã³ã³ãã¥ãŒã¿çæã®DNAç·šéã«åºã¥ããäžèª¿åã§ç Žå£çãªãã®ã§ããããã瀺åããã®ã¯1ã€ã®æ¹åã§ãïŒéºäŒåå®éšã¯åæ¢ããã¹ãã ãšããããšã§ããããã¯ç€ŸäŒå šäœã§æ¥éã«æé·ããŠããçãšãªã£ãŠããŸãã
ãã³ãããã¯ã®åæã«ããããŒãã»ãããŒã³ã®ãããªèåãªç§åŠè ãã¡ã¯ããã®æçœãªå¯èœæ§ããããããé¿ããããªãçµæã«ã€ããŠèŠåããŸãããããã®èŠåã¯ç¡èŠãããŸãããããã«æªãããšã«ã圌ãã®ä¿¡é Œæ§ãæãªãããã®åªåããªããã圌ãã®å ¬çãªçºèšã®å Žãåæ¶ãããŸããããã®æç¹ã§ãèšå€§ãªãã³ãããã¯å©çãèŠèŸŒãŸããŠããŸããããéãšåœ±é¿åã¯ãããããå®çŸãããããã«äœ¿ãããŸãããä»ãWHOã®åæã¯ããã®èŠéãã確ç«ããããšããŠããŸããããã«å察ããªããã°ãªããŸããã幞ãã«ããç±³åœã¯WHOãžã®è³éæäŸãæ€åããŸãããããã¯ãã¥ãŒãžãŒã©ã³ããæ éã«åŠã¶ã¹ãäŸã§ããç§ãã¡ã®ç§åŠæ¿çã¯ãç§åŠçãªçºèŠãç¡èŠããã®ã§ã¯ãªãããããèæ ®ããã¹ãã§ãã
ãªãäžèšã®ãããªç ç©¶ãã¡ãã£ã¢ã§èŠéã鳎ããããšã«ãªããªãã®ãïŒ
ä»å¹Žã®AUTïŒãªãŒã¯ã©ã³ãå·¥ç§å€§åŠïŒã®å¹Žæ¬¡ãã¡ãã£ã¢ãžã®ä¿¡é Œèª¿æ»ãã«ãããšããã¥ãŒãžãŒã©ã³ã人ã®ãã¡ã¡ãã£ã¢ããã»ãšãã©ä¿¡é Œããããšçãã人ã¯32ïŒ ã§ã2020幎åé ã®53ïŒ ãã倧ããæžå°ããŠããŸãã
AUTã®ãžã£ãŒããªãºã ãã¡ãã£ã¢ãæ°äž»äž»çŸ©ç ç©¶ã»ã³ã¿ãŒïŒJMADïŒã®å ±åãã£ã¬ã¯ã¿ãŒã§ããããŒã€ã»ãã«ãªã€ããã£å士ã¯ãä»é±ãTVNZã®ãžã£ãã¯ã»ãã€ã ã®ã€ã³ã¿ãã¥ãŒãåããŸããã圌女ã¯ããã³ãããã¯äžã®ã¡ãã£ã¢å ±éã«å¯Ÿããæ¹å€ã¯äžå ¬å¹³ã ãšè¿°ã¹ãã¡ãã£ã¢ãæ¿åºã®ã¡ãã»ãŒãžããã®ãŸãŸäŒããŠããªãã£ãããã ãšèª¬æããŸããããã«ãªã€ããã£å士ã¯ãã¡ãã£ã¢çµç¹ãçŸåšã圌ããè¡ã£ãŠããããšãããéæã«èª¬æãã誀ããèšæ£ããŠãããšèããŠããããã§ãã
ãã®èªå·±åçã®æ¬ åŠã¯é©ãã¹ããã®ã§ãããè¡æçã§ãããå šãæ··ä¹±ããã€ã³ã¿ãã¥ãŒã®äžã§ããã«ãªã€ããã£å士ã¯ã¢ã¡ãªã«ã®ã¡ãã£ã¢ã®å ¬éèšè«ããæ··ä¹±ããšè¡šçŸããŸãããããããç§ãã¡ã¯ãSubstackãXã®ãããªãªãŒãã³ã¢ã¯ã»ã¹ã®ãã©ãããã©ãŒã ããããæ¿åºãå©å®³é¢ä¿è ãé ããŠããç§åŠç調æ»ã®çµæãå ¬ã«å ±æãè°è«ããããã®æ å ±è»¢éã®å Žã§ããããšãç¥ã£ãŠããŸãã
é©ãã¹ãããšã«ããã«ãªã€ããã£å士ã¯ãªããã¥ãŒãžãŒã©ã³ã人ãã¡ãã£ã¢ãä¿¡é Œããªãã®ãå šãçè§£ããŠããªããšèšããŸããïŒç¬ïŒãããã«ã客芳æ§ãååšããªããšåŠå®ããã»ãšãã©çå®ãæåŠããç§åŠççºèŠãç¡èŠããèš±å¯ãäžãããã®ããã§ããããã®ãã¹ãŠããžã£ãã¯ã»ãã€ã ã¯ææããŸããã§ãããã圌ãç®ã®åã§äœãèµ·ããŠããã®ãã«æ°ã¥ããŠããªãããã§ããã
çå®ã詊ãããã«ã¯3ã€ã®èŠçŽ ãå¿ èŠã§ãïŒ
å人ççµéš â 人ã ã«èµ·ããããšã
ç§åŠçèª¿æ» â è«çãšå®éšãçšããããšã
äŒçµ±çãªäœ¿çš â æéãè¶ ããŠç¶ããïŒ
åœåãæ¿åºã®ã¢ããã€ã¶ãŒãã¡ã¯è£œè¬æ¥çããã€ãªãã¯ãããžãŒæ¥çããã®ã¢ããã€ã¹ãç¡æ¹å€ã«åãå ¥ããéå£ã¯ã¯ãã³æ¥çš®ã¯å®å šã§å¹æçã§ãããšä¿¡ããŠããŸããããã®åŸã圌ãã¯èŽåœçãªèª€ããç¯ããŸããã圌ãã¯æå³çã«ããŸãã¯æ æã«ãäœçŸäžä»¶ã«ãåã¶å¯äœçšã®å ±åãç¡èŠããã®ã§ããããã«ãããç¥èã®åºç€ãšãªãååã®1ã€ã§ãããå人ççµéšããæåŠããããšã«ãªããŸããããŸããéºäŒåæ²»çã«ã¯é·æçãªåœ±é¿ãããããšãç¥ãããŠããã«ãããããããé·æçãªå®å šæ§ã¯ç¢ºç«ãããŠããŸããã§ããããããã軜èŠãããŸããããããèŽåœçãªçµæãããããããã®åœ±é¿ã¯ä»ãç¶ããŠããŸãã
ãã³ãããã¯æ¿çã¯ãç¥èãšããŠæç«ããããã«å¿ èŠãªèšŒæ ã®åºãããæ¬ ããŠããŸãããç§ãã¡ã¯ãç§åŠãä¿¡é ŒããããšèšãããŸããããæäŸãããã®ã¯ç§åŠã§ã¯ãããŸããã§ããããã³ãããã¯æ¿çã¯ãå ¬å ±ã®å¥åº·ã害ãã圢ã§ãã€ããªãã®ãŒãæš©åšã宣äŒãå©çã®ããã®è¡åãšãªã£ãã®ã§ãããããŠãããã¯ä»ãç¶ããŠããŸããä»åŸããWHOãæ¿åºãå»çåœå±ãã¡ãã£ã¢ããããŠãã®ä»ã®å©å®³é¢ä¿è ãæšé²ããŠãã誀ã£ãæ¿çã«å¯ŸããŠçåãæã¡ç¶ããããšãéèŠã§ããã ããããããããã£ãŒãå ±åæžã§ã¯ãçºè¡šãããç§åŠãåŒçšããè«çãåæããäŒçµ±çãªç¥èãåŒçšããæ¹éãæ¡çšããŠããŸããç§ãã¡ã¯çãæ®ãããããæŠããããŠããŸãã声ãäžããã¹ãæã§ãã